Icon

SUBUTEX (nda020732)- (EQ 2MG BASE,EQ 8MG BASE)

BUPRENORPHINE HYDROCHLORIDE INDIVIOR
EQ 2MG BASE,EQ 8MG BASE
No No
Expired Expired
None None
None No
SUBUTEX, contains buprenorphine, a partial opioid agonist, and is indicated for the treatment of opioid dependence and is preferred for induction.
6 0 6
Total Other Developers None
Drugs with Suitability No
EQ 2MG BASE ** ** - - 6
EQ 8MG BASE ** ** - - 6
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****-**** ******** ***. *********** **** ****** ****, ********, **** (**) *****, ****** ****** (***) ***
****** ******* ******* ******** ******* ******* *********** **** ** *-**/* & ***/*, ****, ********** ********* ****,, *****, *********** *** ***, ***** (***) ***
****** ********* ********* *********** ****** ** ** ****** ***
****** ********* ********* ***** ******* *** *********** ** ********** ****, *********, ********** **** ***, ****** ******* (***) ***
****** ********* ********* ** *** *********** ****** ************ *, ********, ******* ****, *********** (***) ***
****** ********* *** ********, *** *** ************** **********, ***. *** *** *** ****** *********** **** ********* ****, **********, ***** ******** (**) *****, ****** ****** (***) ***
****** ******* ********* ***** ******** *** *********** **** ***** *******, **** *****, ***** (**) *****, ****** ****** (***) ***
****** *** ***** *** ************** ********** ******* *********** ****** **. ****, *****, ***** ********* ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** ****** ****** ****** *************** *.*. *********** **** ************* **** *, ******, ***** ******** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.